The Effect of the Finger Feeding Method Applied by Fathers on the Transition Time to Oral Feeding and Sucking Success in Premature Babies
finger feeding
Urogenital Diseases+3
+ Female Urogenital Diseases and Pregnancy Complications
+ Obstetric Labor Complications
Supportive Care Study
Summary
Study start date: February 15, 2024
Actual date on which the first participant was enrolled.This study focuses on helping premature babies in the Neonatal Intensive Care Unit transition more effectively to oral feeding. It aims to explore whether a method called the "finger feeding method," applied by fathers, can improve the success of babies learning to feed by mouth. It involves fathers gently allowing their babies to suck on their fingers before regular feeding times. The study seeks to improve the speed and success of oral feeding in these vulnerable infants, potentially enhancing their overall development and wellbeing. In this study, premature babies are placed into two groups. One group, the experimental group, receives the finger feeding method, where fathers let their babies suck on their fingers for five minutes before nasogastric feeding, three times daily for seven days. The control group receives standard care without this additional stimulation. Researchers use tools like the Preterm Baby Monitoring Form and LATCH Breastfeeding Diagnostic Measurement Tool to assess how quickly the babies transition to oral feeding and how successful they are at breastfeeding. This method provides a safe way to encourage feeding skills in premature infants, with the potential benefit of faster development. There are no specified risks involved in the study.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.64 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Male
Biological sex of participants that are eligible to enroll.From 18 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location